Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study
<p>Abstract</p> <p>Background</p> <p>Only few studies have assessed safety of in utero exposure to glatiramer acetate (GA). Following a previous study assessing the safety of interferon beta (IFNB) pregnancy exposure in multiple sclerosis (MS), we aimed to assess pregna...
Main Authors: | Giannini Marta, Portaccio Emilio, Ghezzi Angelo, Hakiki Bahia, Pastò Luisa, Razzolini Lorenzo, Piscolla Elisa, De Giglio Laura, Pozzilli Carlo, Paolicelli Damiano, Trojano Maria, Marrosu Maria, Patti Francesco, La Mantia Loredana, Mancardi Gianluigi, Solaro Claudio, Totaro Rocco, Tola Maria, De Luca Giovanna, Lugaresi Alessandra, Moiola Lucia, Martinelli Vittorio, Comi Giancarlo, Amato Maria |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2377/12/124 |
Similar Items
-
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study
by: Pastò Luisa, et al.
Published: (2012-12-01) -
Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months Tolerabilidade, eventos adversos e aderência ao acetato de glatiramer em 28 pacientes com esclerose múltipla usando a droga continuamente por pelo menos seis meses
by: Ana Patricia Perez Fiore, et al.
Published: (2005-09-01) -
Glatiramer Acetate-associated Refractory Immune Thrombocytopenic Purpura
by: Iftach Sagy, et al.
Published: (2016-04-01) -
Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers
by: Oliver Neuhaus, et al.
Published: (2021-03-01) -
Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
by: Lyubomira Vlahova, et al.
Published: (2021-02-01)